| Natera, Inc. Common Stock | $32.0b | $261.00 | -0.0% | 2.2M | |
| Guardant Health, Inc. Common Stock | $17.2b | $150.70 | +4.5% | 3.7M | |
| Caris Life Sciences, Inc. Common Stock | $4.7b | $18.71 | -1.0% | 4.0M | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $118.06 | +5.1% | 896.9K | |
| Veracyte, Inc. | $3.7b | $60.50 | +3.3% | 1.1M | |
| GRAIL, Inc. Common Stock | $3.1b | $65.97 | -1.1% | 401.6K | |
| Adaptive Biotechnologies Corporation Common Stock | $2.4b | $21.02 | +3.4% | 2.7M | |
| NeoGenomics, Inc. | $1.4b | $14.13 | +3.2% | 2.7M | |
| Personalis, Inc. Common Stock | $1.2b | $12.70 | +2.9% | 4.0M | |
| Castle Biosciences, Inc. Common Stock | $0.6b | $24.25 | +5.9% | 389.0K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.98 | +2.8% | 324.8K | |
| AngioDynamics, Inc. | $474.3m | $13.41 | -2.2% | 435.9K | |
| The Oncology Institute, Inc. Common Stock | $468.9m | $5.30 | +4.9% | 2.3M | |
| Myriad Genetics Inc | $375.0m | $5.69 | +7.7% | 2.5M | |
| Lucid Diagnostics Inc. Common Stock | $196.5m | $1.08 | +1.9% | 1.6M | |
| Biodesix, Inc. Common Stock | $169.0m | $22.89 | +11.7% | 129.3K | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $1.52 | +8.3% | 64.7M | |
| Sensus Healthcare, Inc | $50.9m | $2.96 | +2.7% | 53.7K | |
| PAVmed Inc. Common Stock | $44.4m | $5.09 | +12.0% | 28.0K | |
| Precipio, Inc. Common Stock | $40.8m | $23.05 | +1.0% | 48.1K | |
| MDxHealth SA Ordinary Shares | $39.0m | $0.44 | -2.3% | 1.1M | |
| VolitionRx Limited | $22.2m | $1.30 | -0.7% | 120.9K | |
| 20/20 Biolabs, Inc. Common Stock | $9.2m | $0.59 | 0.0% | 152.8K | |
| Advanced Biomed Inc. Common Stock | $8.2m | $4.50 | -7.5% | 3.3K | |
| bioAffinity Technologies, Inc. Common Stock | $7.6m | $0.84 | +0.9% | 138.2K | |
| Avalon GloboCare Corp. Common Stock | $4.3m | $0.29 | -7.8% | 728.4K | |
| Onconetix, Inc. Common Stock | $1.4m | $1.00 | -2.0% | 99.8K | |
| Zhongchao Inc. Class A Ordinary Shares | $0.6m | $0.33 | -17.2% | 41.9M |